SUBSCRIBE
SUBSCRIBE
News   Business

Alnylam Pharmaceuticals Reports First Quarter 2007 Financial Results

May 10, 2007 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the quarter ended March 31, 2007 and company highlights.
Earnings
Alnylam Pharmaceuticals
MORE ON THIS TOPIC
Accumulated problems, contradictions. Dead end, we need to go back. You cannot continue further. Complete impossibility to continue. Rejection of an idea. Hard sanctions. Fatal error.
CAR-T
Regeneron Cans 2seventy-Acquired CAR T Candidate for Lymphoma in ‘Strategic’ Move
October 24, 2025
 · 
2 min read
 · 
Tristan Manalac
Map with different syringes. Covid 19 and pandemic vaccination concept. Vector illustration
Earnings
Sanofi’s Legacy Vaccine Sales Decline As Americans Skip Flu Shots
October 24, 2025
 · 
2 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Alector Nearly Halves Workforce Following Dementia Drug Phase III Failure
October 23, 2025
 · 
74 min read
 · 
BioSpace Editorial Staff
Earnings
MASH, Metsera Deals Send Analysts Marauding to Viking
October 23, 2025
 · 
6 min read
 · 
Annalee Armstrong